CYBERDYNE Inc. 7779
TSE · Japan · Health Technology
¥231.00-5.00 (-2.12%)
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
SAN JOSE, Calif., June 16, 2026--Pegasus Tech Ventures, a Silicon Valley–based global venture capital firm and leading provider of Venture Capital-as-a-Service (VCaaS) solutions, today announced the launch of a JPY 10 billion (US $60M) Corporate Venture Capital (CVC) fund in partnership with CYBERDYNE, Inc., a leading company in the field of Cybernics that fuses bio/medical systems with AI-robotics and information technologies.
The global walk assist robot market is set to expand at a 15.01% CAGR from 2024 to 2031, driven by AI, machine learning, and hybrid wearable robotics. Growing demand stems from rising stroke incidences and an aging population, enhancing rehabilitation and mobility. Despite high costs limiting adoption, the wearable exoskeleton segment leads, favored for its clinical effectiveness. North America, especially the U.S., dominates the market due to healthcare advancements, with Europe and APAC also e
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.